BIOMATERIALS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Biomaterials Market Size and Forecast – 2025 to 2032

The Global Biomaterials Market is estimated to be valued at USD 208.23 Bn in 2025 and is expected to reach USD 577.93 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 15.8% from 2025 to 2032The growth in the Global Biomaterials Market is driven by increasing demand in medical applications such as tissue engineering, drug delivery, and implants. Advancements in biotechnology and rising R&D investments are fueling innovation in biomaterials, particularly in regenerative medicine and orthopedic implants.

Key Takeaways of the Global Biomaterials Market

• Metallic biomaterials are projected to hold the largest market share in the global biomaterials market, accounting for 40.1% in 2025.
• Orthopedic applications are expected to dominate the biomaterials market, representing 30.2% of the market share in 2025.
• Additionally, 3D printing technology is expected to lead the biomaterials market, capturing 31.4% of the market share in 2025.
• North America is expected to lead the market, holding a share of 38.8% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 24.5% in 2025.

Market Overview

The market trend is characterized by a shift towards the development of sustainable and bioactive materials, which enhance tissue regeneration and reduce the risk of transplant rejection. Additionally, the integration of nanotechnology and 3D printing in biomaterial manufacturing is gaining momentum, enabling customizable and patient-specific implants. An emphasis on eco-friendly materials and regulatory support further propels adoption, paving the way for biomaterials to revolutionize sectors such as healthcare, dentistry, and wound care.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Biomaterials Market Insights, By Material Type - Metallic biomaterials contributes the highest share of the market owing to their superior mechanical properties and versatile applications

Metallic biomaterials are leading the global biomaterials market and will account for 40.1% of the market share in 2025. Their dominance is mainly due to the combination of properties such as the unmatched strength and biocompatibility which make them suitable for a multitude of medical applications. Titanium and its alloys, along with cobalt-chromium alloys, are particularly favored in this segment due to their corrosion resistance and high fatigue strength. These properties make them ideal materials for weight-bearing implants, such as hip and knee replacements.

The heavy use of metallic biomaterials in orthopedic and dental implants clearly signals their acceptance in clinical practices. Their property of being able to properly be physically bonded to human tissue, especially when surface-treated to improve osseointegration, further fortifies their claiming of suitability for being used as permanent implants.

Biomaterials Market Insights, By Application - Orthopedic sector leads the biomaterials market driven by an aging population and rise in musculoskeletal disorders

Orthopedic applications are expected to represent 30.2% of the biomaterials market by 2025, making it the largest segment. This growth is driven by the increasing prevalence of bone and joint disorders such as arthritis, osteoporosis, and fractures. As these degenerative musculoskeletal conditions are more common with aging, there will continue to be a steady demand for advanced orthopedic implants and devices.

On October 21, 2025, Heraeus Medical, a leader in bone cements and biomaterials for orthopedics and trauma surgery, expanded its product portfolio with the launch of heracure, a line of resorbable biomaterials for bone regeneration.

Biomaterials Market Insights, By Technology - 3D printing leads biomaterials market growth due to customization and rapid prototyping capabilities

3D printing technology is leading the biomaterials market with an estimated share of 31.4% in 2025 as it offers the most flexibility and precision in customizable medical device production. It creates implants and prostheses that are specific to patients according to their individual anatomical requirements. This way it solves one of the key problems in biomaterial applications: achieving perfect fit and integration with the patient’s body.

The additive manufacturing technique of layer-by-layer has opened the door to intricate shapes that were either too hard or even impossible to get with the traditional processes. Thus, the implant's power of design has been improved by this flexibility and has led to the implant having better mechanical and biological characteristics while at the same time, reducing surgical difficulties.

Regional Insights

To learn more about this report, Download Free Sample

North America Biomaterials Market Analysis and Trends

North America is expected to dominate the global biomaterials market with a considerable portion of 38.8% in 2025, mainly owing to a well-established medical device industry, significant R&D infrastructure, and government policies that are favorable. The U.S. is in a great position because of the heavy funding for biocompatible materials and the assistance from regulatory agencies such as the NIH and U.S. FDA. Partnerships between the academic and industrial sectors drive innovation in the biomaterials market. Medtronic, Johnson & Johnson, and Stryker hold the largest market share, primarily through the widespread use of biomaterials in orthopedic implants and drug delivery systems.

In March 2023, Invibio Biomaterial Solutions, a leader in advanced biomaterials, launched Peek-Optima Am, a polyetheretherketone polymer-based filament for manufacturing 3D-printed medical devices.

Asia Pacific Biomaterials Market Analysis and Trends

The Asia Pacific region is expected to be the fastest-growing region, accounting for 24.5% share in 2025, mainly due to various factors such as higher healthcare allocations, increasing rates of chronic diseases, and the growing use of biomaterial-based therapeutic devices. As a result of the economic growth in China and India, there are opportunities to invest in healthcare and open new labs for education and research.

Incentives from the state, such as China's Made in China 2025 and India's BIRAC programs, are making it easier to produce goods locally and are also attracting foreign investments. Increased access to healthcare and higher public awareness are additional factors driving demand. For example, Shandong Weigao Group and Fosun Pharma are extending their biomaterial products and also joining forces with international companies to tap into the thriving market opportunities.

Biomaterials Market Outlook for Key Countries

U.S. Biomaterials Market Trends

The biomaterials market of the U.S. continues to be a dominating force in the world backed by its sophisticated infrastructures of healthcare and a dynamic sector of biotechnology. The world's largest players including Medtronic and Johnson & Johnson are constantly putting their money into researches to develop biomaterial technologies that are advanced like nanocomposites and bioactive coatings for the implants. The U.S. has a strong system of intellectual property rights along with a regulatory environment that is supportive which in turn speeds up the process of clinical trials and approvals.

In April 2025, Northern Illinois University (NIU) launched a state-of-the-art biomaterials and tissue engineering lab, enhancing its biomedical engineering program. The new "wet lab," the first of its kind at the College of Engineering and Engineering Technology (CEET), allows students to conduct experiments involving liquids, chemicals, and biological matter.

China Biomaterials Market Trends

China is now a rapidly growing biomaterials market since the government has decided to modernize the healthcare sector and also develop the biopharmaceuticals industry. Manufacturers like Shandong Weigao Group and MicroPort Scientific are aiming at large patient groups and thus are trying to produce biomaterial goods that are cheap. The country’s legal changes have made product approvals easy, thus fostering innovation and local production.

In October 2021, a study published in Sec. Integrative and Regenerative Pharmacology explored the role of Traditional Chinese Medicine (TCM) in musculoskeletal tissue engineering (MTE) using biomaterials. The review highlighted how bioactive herbal extracts from TCM can regulate key processes like osteogenesis, angiogenesis, and anti-inflammation, making them promising for enhancing the effectiveness of biomaterials in musculoskeletal regeneration.

Germany Biomaterials Market Trends

Germany is the dominant country in Europe's biomaterials market due to its industrial base and skilled personnel in the field of biomedical engineering. Manufacturing and quality control requirements coupled with extensive public and private R&D funding are the reasons for developing new products like biodegradable implants and smart biomaterials. Germany also has the advantage of having a strong relationship between research universities and industry clusters, which allows for quick commercialization.

B.Braun Melsungen, a German medical and pharmaceutical device company, has developed biodegradable biomaterials such as Lyoplant, a collagen implant obtained from bovine pericardium, used for the replacement and extension of connective tissue structures in neurosurgery.

India Biomaterials Market Trends

The biomaterials market in India is experiencing an upward trend due to the rising investments in technologies and health infrastructure which are supported by various government schemes like Make in India and also the Central Drugs Standard Control Organization (CDSCO) that provides regulation support. Companies like Poly Medicure and Jubilant Life Sciences are augmenting their biomaterial portfolios to cater to the growing domestic market, especially in the areas of wound care and dental biomaterials.

In October 2023, Prevest DenPro Limited, an Indian leader in dental materials, launched three innovative biomaterials for endodontic, restorative, and orthodontic applications. Developed using indigenous technology by the company’s in-house R&D team, the products were unveiled at an event attended by prominent dental healthcare figures, including Prof. Dr. O.P. Kharbanda.

End User Feedback and Unmet Needs in the Global Biomaterials Market

• Biomaterials are commended and criticized by end users from various industries such as healthcare and manufacturing. Medical practitioners usually acknowledge the durability and bio-compatibility of bio-based materials in implants, which in turn deliver better patient outcomes.
• Cost is the main factor that the healthcare sector is worried about and the high price continues to be a barrier to access for small health providers especially in the developing world. User complaints about the lack of custom-made bio-composites in the manufacturing sector, which require expensive alterations for certain applications, thus causing the delay of projects.
• The call for cheaper and more personalized biomaterials is very clear. Unmet needs in this area can be turned into the advantages of not only customer loyalty but also an opening for growth in sectors previously blocked by the lack of finance or technology.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In August 2025, IMDEA Materials Institute, a leader in advanced materials research, appointed Prof. Andrés Díaz Lantada as Principal Investigator to lead a new research line focused on bioinspired, smart, and living biomaterials. This initiative strengthens the Institute’s "Materials for Health" area, aiming to develop medical devices using emerging materials that mimic biological systems.
• In December 2024, Amir Zadpoor, PhD, highlighted the potential of 4D-printed biomaterials for tissue regeneration in a discussion on how these materials adapt to the changing needs of the human body. Unlike traditional static biomaterials, 4D-printed materials can change shape in response to stimuli such as humidity, temperature, and pressure, inspired by natural structures like the pinecone.
• In October 2024, attivaretx licensed immune-modulating biomaterial technology from the Wyss Institute at Harvard University. The technology aims to develop novel immunotherapies for solid tumors and blood cancers that don't respond to current treatments, using biomaterials to enhance immune system training and cancer immunity.
• In December 2022, Stryker launched the Citrefix Suture Anchor System, featuring Citregen, an innovative biomaterial designed to mimic native bone for bone regeneration and healing. The system supports controlled resorption, minimizing inflammation, and expands Stryker's biomaterial portfolio for enhanced orthopedic outcomes.

Top Strategies Followed by Global Biomaterials Market Players

• Major players in the market, through their heavy investments in research and development (R&D), are mainly focusing on to create high-performance biomaterials which will last longer, have better compatibility with human tissues, and functionality than the existing ones. Besides, these players are forming strategic partnerships and alliances with the leading industry players, including the original equipment manufacturers (OEMs), to strengthen their position and utilize their combined strengths in technology and distribution.
  • In January 2023, Zimmer Biomet., which is a global leader in the medical device market, disclosed its intention to purchase Embody, Inc. for a total of USD 155 million, while also considering an additional payment of up to USD 275 million subject to the achievement of future milestones. The deal intends to augment Zimmer Biomet's sports medicine line with the accent on soft tissue repair products.

• The biomaterials market is characterized by an array of competing companies each with different strategies and approaches; nonetheless, the mid-tier companies have a more practical and down to earth mentality offering basic solutions that give the best quality/price ratio. Their positioning will attract not only the price-conscious consumers but also the new markets where demand for the lowest prices is the key factor in procurement decisions.
  • For instance, Bezwada Biomedicals, based in the U.S., specializes in absorbable polymers with improved functionality, including hydrolyzable polyurethanes and functionalized natural products. These materials are prepared for controlled drug release and antimicrobial applications, expanding the possibilities of therapy.

• The competition among small-scale players in the biomaterials sector is mainly about creating new and highly specific products and having their own unique niches. These companies are often highlighting the unique properties of biomaterials for medical uses, such as coatings, implants, or composites that combine different materials and are biodegradable and lightweight.
  • Small-scale players focus their specialization by developing innovative, targeted products. A Turkish startup, MPLUSHEAL, is turning human hair waste into sustainable materials by isolating keratin for use in regenerative medicine, tissue engineering, and trauma care. This innovative process turns waste into precious biomaterials.

Market Report Scope

Biomaterials Market Report Coverage

Biomaterials Market Dynamics

To learn more about this report, Download Free Sample

Biomaterials Market Driver - Rising Prevalence of Chronic Diseases and Aging Population

The prevalence of chronic illnesses like heart diseases, diabetes, osteoarthritis, and cancer besides the worldwide growing elderly population are major factors that are pushing the demand for potent biomaterials enormously. Long medical treatments, implants, and repairing tissues often required by the mentioned health conditions, hence the demand for biocompatible and durable materials has become stronger. The aging population is more prone to degenerative diseases and accidents that lead to surgeries and implantable devices, thus the cycle of demand for biomaterials in healthcare gets repeatable.

In September 2025, the World Health Organization (WHO) revealed that the burden of chronic or noncommunicable diseases, which had already taken around 43 million lives in 2021, claimed 75% of all non-pandemic-related deaths. They based their findings on global statistics from September 2025. The data pointed out that the main culprits were cardiovascular diseases, cancers, chronic respiratory conditions, and diabetes, with 80% of the premature deaths taking place in low- and middle-income countries.

Biomaterials Market Opportunity - Advancements in Bioactive and Smart Biomaterials

The constant development of bioactive and smart biomaterials creates a huge potential for the global biomaterials market reshaping towards a highly innovative and growth-oriented direction. More and more, bioactive materials that are meant to interact in a beneficial way with the biological tissues are being developed to help tissues heal faster, regenerate and implant integration more efficiently. In fact, they provide better performance than traditional inert biomaterials by engaging cell and biological environment activity; this engagement is crucial in areas like orthopedics, cardiovascular devices, and wound care.

In October 2023, Evonik, a global leader in specialty chemicals and biomaterials, introduced VESTAKEEP iC4612 3DF and iC4620 3DF, the world’s first carbon-fiber-reinforced PEEK filaments for 3D-printed medical implants. This innovation underscores Evonik's commitment to advancing patient-specific medical treatments using cutting-edge biomaterials.

Analyst Opinion (Expert Opinion)

• Biomaterials are one of the fastest-growing markets in the world, the main drivers being the technological developments, of which, in medical devices and implants, are the biocompatible materials and new 3D printing tech, as well as the increasing healthcare demands and steady regulatory support. Besides, governmental initiatives such as “Made in China 2025” in China and “BIRAC” in India are stimulating local innovation and manufacturing; the increasing consumer awareness about affordable healthcare solutions is creating new market areas.
• The medical sector is a key player in biomaterials application, but there remains a gap between recognizing their benefits and their current use. The industry continues to face challenges like limited R&D funding, regulatory hurdles, and innovation pressures. Progress can be made through partnerships between academia and industry, as well as developing healthcare infrastructure in developing countries. Events like the "International Biomaterials Symposium" and "Biomaterials and Biomedical Engineering Congress" are crucial in driving innovation and shaping the future of the biomaterials market.

Market Segmentation

• Material Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Metallic Biomaterials
    • Titanium and Titanium Alloys
    • Cobalt-Chrome Alloys
    • Others
  • Polymeric Biomaterials
    • Polymethyl Methacrylate (PMMA)
    • Polyetheretherketone (PEEK)
    • Others
  • Ceramic Biomaterials
    • Calcium Phosphate
    • Zirconia
    • Others
  • Natural Biomaterials
    • Collagen and Gelatin
    • Hyaluronic Acid
    • Others
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Orthopedic
  • Cardiovascular
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Neurological Disorders
  • Ophthalmology
  • Drug Delivery Systems
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • 3D Printing
  • Nanotechnology
  • Electrospinning
  • Bioprinting
  • Hydrogels Technology
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Research Laboratories
  • Biotechnology and Pharmaceutical Companies
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • BASF SE
  • Covestro AG
  • Celanese Corporation
  • Carpenter Technology Corporation
  • Royal DSM
  • Evonik Industries AG
  • Berkeley Advanced Biomaterials
  • Cam Bioceramics B.V.
  • Corbion N.V.
  • Lubrizol Corporation
  • Zimmer Biomet Holdings Inc
  • Stryker Corporation
  • Johnson and Johnson
  • Medtronic PLC
  • Boston Scientific Corporation

Sources

Primary Research Interviews

• Industry Stakeholders
  • Key experts in the medical device and biomaterials industry
  • Representatives from leading academic and research institutions
• End Users
  • Hospitals and healthcare providers
  • Patients and consumer groups involved in biomaterial treatments

Government and International Databases

• National Institutes of Health (NIH)
• U.S. Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• World Health Organization (WHO)
• U.S. Centers for Disease Control and Prevention (CDC)
• European Commission – Research and Innovation

Trade Publications

• Medical Device and Diagnostic Industry (MD+DI)
• BioMaterials Magazine
• MedTech Dive
• Medical Plastics News
• Biomaterials Science Journal
• Medical Design & Outsourcing

Academic Journals

• Acta Biomaterialia
• Biomaterials
• Journal of Biomaterials Science, Polymer Edition
• Journal of Functional Biomaterials
• Biofabrication
• Journal of Biomedical Materials Research Part A

Reputable Newspapers

• The New York Times – Health Section
• The Guardian – Science and Technology
• The Wall Street Journal – Health and Science
• Financial Times – Health Industry
• Reuters – Health News
• Bloomberg – Healthcare

Industry Associations

• Society for Biomaterials (SFB)
• European Society for Biomaterials (ESB)
• American Society for Testing and Materials (ASTM)
• International Society for Biofabrication (ISBF)
• International Union of Societies for Biomaterials Science and Engineering (IUS-BSE)
• Biomaterials Society of India (SBAOI)

Public Domain Resources

• National Center for Biotechnology Information (NCBI)
• U.S. National Library of Medicine (NLM)
• European Bioinformatics Institute (EBI)
• World Intellectual Property Organization (WIPO)
• U.S. Patent and Trademark Office (USPTO)

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years